Cormorant Asset Management, LP
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ERASCA INC(ERAS) | 0 | 5,800,000 | +5,800,000 | 0 | 93,844,000 | 4.73% | +93,844,000 |
| DIANTHUS THERAPEUTICS INC(DNTH) | 0 | 950,000 | +950,000 | 0 | 79,724,000 | 4.02% | +79,724,000 |
| ALUMIS INC | 3,635,596 | 3,949,241 | +313,645 | 35,483,417 | 87,001,779 | 4.39% | +51,518,362 |
| DAMORA THERAPEUTICS INC(DMRA) | 0 | 1,525,000 | +1,525,000 | 0 | 39,497,500 | 1.99% | +39,497,500 |
| TANGO THERAPEUTICS INC(TNGX) | 0 | 1,425,000 | +1,425,000 | 0 | 29,811,000 | 1.50% | +29,811,000 |
| MOONLAKE IMMUNOTHERAPEUTICS(MLTX) | 4,355,433 | 4,480,433 | +125,000 | 57,404,607 | 83,515,271 | 4.21% | +26,110,664 |
| AGOMAB THERAPEUTICS NV | 0 | 2,465,348 | +2,465,348 | 0 | 25,861,501 | 1.30% | +25,861,501 |
| BIOAGE LABS INC(BIOA) | 2,040,605 | 2,890,605 | +850,000 | 26,997,204 | 50,556,681 | 2.55% | +23,559,477 |
| MAZE THERAPEUTICS INC(MAZE) | 0 | 750,000 | +750,000 | 0 | 22,387,500 | 1.13% | +22,387,500 |
| EDGEWISE THERAPEUTICS INC(EWTX) | 3,285,000 | 3,260,000 | -25,000 | 81,517,275 | 102,690,000 | 5.18% | +21,172,725 |
| ROIVANT SCIENCES LTD(ROIV) | 0 | 750,000 | +750,000 | 0 | 20,775,000 | 1.05% | +20,775,000 |
| ADLAI NORTYE LTD | 0 | 2,897,857 | +2,897,857 | 0 | 20,053,170 | 1.01% | +20,053,170 |
| TERNS PHARMACEUTICALS INC | 0 | 300,000 | +300,000 | 0 | 15,816,000 | 0.80% | +15,816,000 |
| BIOHAVEN LTD(BHVN) | 10,000 | 1,760,000 | +1,750,000 | 112,900 | 14,889,600 | 0.75% | +14,776,700 |
| HELIX ACQUISITION CORP III | 0 | 1,297,500 | +1,297,500 | 0 | 13,182,600 | 0.66% | +13,182,600 |
| ORUKA THERAPEUTICS INC(ORKA) | 533,340 | 533,340 | 0 | 16,165,535 | 26,160,327 | 1.32% | +9,994,792 |
| SENSEI BIOTHERAPEUTICS INC | 0 | 306,222 | +306,222 | 0 | 9,652,117 | 0.49% | +9,652,117 |
| ZURA BIO LTD | 0 | 1,450,000 | +1,450,000 | 0 | 8,627,500 | 0.43% | +8,627,500 |
| CENTESSA PHARMACEUTICALS PLC | 1,325,000 | 1,050,000 | -275,000 | 33,138,250 | 41,706,000 | 2.10% | +8,567,750 |
| STRUCTURE THERAPEUTICS INC | 0 | 175,000 | +175,000 | 0 | 8,435,000 | 0.43% | +8,435,000 |
| OLEMA PHARMACEUTICALS INC(OLMA)(Call) | 0 | 500,000 | +500,000 | 0 | 7,455,000 | — | +7,455,000 |
| MONTE ROSA THERAPEUTICS INC(GLUE) | 0 | 400,000 | +400,000 | 0 | 6,580,000 | 0.33% | +6,580,000 |
| ARROWHEAD PHARMACEUTICALS IN(ARWR) | 0 | 100,000 | +100,000 | 0 | 6,270,000 | 0.32% | +6,270,000 |
| PRAXIS PRECISION MEDICINES I(PRAX) | 950,000 | 885,500 | -64,500 | 280,003,000 | 285,299,245 | 14.38% | +5,296,245 |
| CABALETTA BIO INC | 4,400,000 | 5,500,000 | +1,100,000 | 9,636,000 | 14,795,000 | 0.75% | +5,159,000 |
| RALLYBIO CORP | 0 | 400,000 | +400,000 | 0 | 3,588,000 | 0.18% | +3,588,000 |
| CORBUS PHARMACEUTICALS HLDGS | 2,344,971 | 2,344,971 | 0 | 19,088,064 | 22,019,278 | 1.11% | +2,931,214 |
| CONTEXT THERAPEUTICS INC | 0 | 529,550 | +529,550 | 0 | 1,387,421 | 0.07% | +1,387,421 |
| RAPPORT THERAPEUTICS INC(RAPP) | 3,027,521 | 2,957,521 | -70,000 | 91,854,987 | 92,540,832 | 4.67% | +685,845 |
| ASCENDIS PHARMA A/S(ASND) | 100,000 | 95,000 | -5,000 | 21,324,000 | 21,729,350 | 1.10% | +405,350 |
| VAXCYTE INC(PCVX) | 125,000 | 100,000 | -25,000 | 5,767,500 | 5,811,000 | 0.29% | +43,500 |
| AMYLYX PHARMACEUTICALS INC(AMLX) | 400,000 | 350,000 | -50,000 | 4,832,000 | 4,865,000 | 0.25% | +33,000 |
| COGENT BIOSCIENCES INC(COGT) | 225,000 | 200,000 | -25,000 | 7,992,000 | 7,698,000 | 0.39% | -294,000 |
| PHARVARIS N V COM | 1,083,000 | 1,000,000 | -83,000 | 30,053,250 | 28,250,000 | 1.42% | -1,803,250 |
| MBX BIOSCIENCES INC(MBX) | 1,120,000 | 1,120,000 | 0 | 35,324,800 | 33,432,000 | 1.69% | -1,892,800 |
| ARCUTIS BIOTHERAPEUTICS INC(ARQT) | 500,000 | 450,000 | -50,000 | 14,520,000 | 10,602,000 | 0.53% | -3,918,000 |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 1,000,000 | 950,000 | -50,000 | 35,080,000 | 30,409,500 | 1.53% | -4,670,500 |
| TARSUS PHARMACEUTICALS INC(TARS) | 250,000 | 225,000 | -25,000 | 20,470,000 | 15,783,750 | 0.80% | -4,686,250 |
| CRINETICS PHARMACEUTICALS IN(CRNX) | 300,000 | 250,000 | -50,000 | 13,965,000 | 9,080,000 | 0.46% | -4,885,000 |
| AXSOME THERAPEUTICS INC.(AXSM) | 75,000 | 50,000 | -25,000 | 13,698,000 | 8,451,000 | 0.43% | -5,247,000 |
| BRIGHT MINDS BIOSCIENCES INC | 1,059,331 | 1,059,331 | 0 | 82,670,191 | 77,299,383 | 3.90% | -5,370,808 |
| JANUX THERAPEUTICS INC(JANX) | 650,000 | 0 | -650,000 | 8,970,000 | 0 | — | -8,970,000 |
| OLEMA PHARMACEUTICALS INC(OLMA) | 2,750,000 | 3,900,000 | +1,150,000 | 68,750,000 | 58,149,000 | 2.93% | -10,601,000 |
| GH RESEARCH PLC(GHRS) | 1,300,000 | 0 | -1,300,000 | 16,510,000 | 0 | — | -16,510,000 |
| INSMED INC(INSM) | 275,000 | 190,000 | -85,000 | 47,861,000 | 31,068,800 | 1.57% | -16,792,200 |
| BRIDGEBIO PHARMA INC(BBIO) | 1,200,000 | 850,000 | -350,000 | 91,788,000 | 63,121,000 | 3.18% | -28,667,000 |
| ENGENE HOLDINGS INC COM | 4,000,000 | 0 | -4,000,000 | 36,120,000 | 0 | — | -36,120,000 |
| EYEPOINT INC(EYPT) | 8,265,000 | 8,265,000 | 0 | 151,001,550 | 106,535,850 | 5.37% | -44,465,700 |
| BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | 17,878,594 | 0 | 223,839,997 | 160,013,416 | 8.07% | -63,826,581 |
| ABIVAX SA(ABVX) | 1,350,000 | 760,000 | -590,000 | 182,054,250 | 84,626,000 | 4.27% | -97,428,250 |
| SPDR SERIES TRUST(Put) ST STR SP BIOT | 1,000,000 | 0 | -1,000,000 | 121,930,000 | 0 | — | -121,930,000 |
| ISHARES TR(Put) | 500,000 | 0 | -500,000 | 123,080,000 | 0 | — | -123,080,000 |
| INVESCO QQQ TR(Put) | 250,000 | 0 | -250,000 | 153,577,500 | 0 | — | -153,577,500 |